MedPath
HSA Approval

SILDENAFIL PHARMATHEN FILM-COATED TABLET 50MG

SIN15175P

SILDENAFIL PHARMATHEN FILM-COATED TABLET 50MG

SILDENAFIL PHARMATHEN FILM-COATED TABLET 50MG

February 14, 2017

SEA PHARMA CONSULTANCY PTE LTD

SEA PHARMA CONSULTANCY PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSEA PHARMA CONSULTANCY PTE LTD
Licence HolderSEA PHARMA CONSULTANCY PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

G04BE03

sildenafil

Manufacturer Information

SEA PHARMA CONSULTANCY PTE. LTD.

Jubilant Generics Limited

Active Ingredients

(Intragranular Material) Sildenafil Citrate 70.241mg eqv Sildenafil

50mg

Sildenafil

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SILDENAFIL PHARMATHEN FILM-COATED TABLET 50MG - HSA Approval | MedPath